A new PicoWay® system handpiece is FDA-cleared to treat benign pigmented lesions and blue & green tattoo removal. This highly specialized tool for pigment removal delivers the precise balance of optimized wavelength and pulse duration to remove boldly and treat lightly.
730 nm Optimized Wavelength: Highly targeted melanin absorption with decreased absorption of hemoglobin, an unintended target when treating benign pigmented lesions
250 ps Shortest Pulse Duration: Only 250 picoseconds, to reduce thermal impact and boost photoacoustic effect
Download our Brochure today to learn more about the 730nm handpiece! A copy will be sent to your inbox momentarily.
Disclaimer: The views and opinions expressed in this panel discussion are those of the authors and do not necessarily represent the official position of Candela Corporation or its affiliates. All contents of this material are for informational purposes only and provided by Candela Asia-Pacific without warranties of any kind. Healthcare professionals are solely responsible for making their own independent evaluation as to the suitability of any product for any particular purpose and in accordance with country-specific regulations. The availability of products and the indications mentioned in this material is subject to the regulatory requirements and product registration status in each country. Refer to the User Manual for country-specific indications. Products and technical specifications may change without notice. Please contact Candela Asia-Pacific for more details.
©2022 Candela Corporation. This material contains registered and unregistered trademarks, trade-names, service marks and brand names of Candela Corporation and its affiliates. All other trademarks are the property of their respective owners. All rights reserved.
NOT ALL PRODUCTS ARE LICENSED IN YOUR COUNTRY, PLEASE CHECK WITH YOUR LOCAL REPRESENTATIVE. ALL PERSONAL DATA SUBMITTED TO CANDELA VIA THIS WEBSITE WILL BE HELD IN ACCORDANCE WITH OUR PRIVACY NOTICE, WHICH CAN BE VIEWED HERE. © 2020 CANDELA CORPORATION. ALL RIGHT RESERVED.